市場調査レポート
商品コード
1410805
女性不妊手術機器の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年)Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
女性不妊手術機器の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年) |
出版日: 2023年12月13日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
女性不妊手術機器の使用は、大半の国々で教育水準と所得が向上し、今後も安定して(非常に低い減少率/増加率で)推移する可能性があります。
可逆的方法と男性不妊手術の人気が高まっています。パイプカットは失敗しても子宮外妊娠のリスクが高まらないため、女性不妊手術よりも安全であると考えられています。しかし、性感染症のリスクを軽減し、副作用のない、または副作用の小さい、新たな低コストの技術/機器の導入が、卵管クリップ/リング市場を大きく抑制し、将来に新たな機会を生み出す可能性があります。
当レポートでは、世界の女性不妊手術機器市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。
市場モデルの主な内容は以下の通りです。
上市済みの女性不妊手術機器と進化する競合情勢
世界、地域、国レベルの市場固有の考察
医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。
対象企業
Not Applicable
Not Applicable
Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Reproductive Health Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Female Sterilization Devices market for the year 2020 and beyond. Female sterilization is a permanent procedure where the fallopian tubes are blocked using surgical and non-surgical techniques. Use of female sterilization devices may remain stable (with very low rates of decline/increase) in future with greater educational attainment and income in most of the countries.
Reversible methods and male sterilization are increasing in popularity; vasectomy is considered to be safer than female sterilization as there is no increased risk of ectopic pregnancy if vasectomy fails. However, introduction of new and low cost technologies/devices that reduce the risk of STD's, and cause no/less side effects may hinder the tubal clips/rings market to a large extent and may generate new opportunities in the future.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Female Sterilization Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Utah Medical Products Inc, Olympus Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable